Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Heart Failure Insomnia Treatment Study [NA]
A completed clinical trial update from Ohio State University evaluating insomnia treatment in patients with heart failure; the status is com…
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Evaluation of the Effect of Liposomal L-Arg and Vit C Integration on Mitochondrial Function in Patients With Heart Failure [Phase 3]
Phase 3 clinical trial evaluating liposomal L-Arginine and vitamin C on mitochondrial function in patients with heart failure; currently rec…
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure [NA]
A completed clinical trial investigating a pragmatic urinary sodium-based treatment algorithm in acute heart failure; results posted in 2024…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: CardioMEMS HF System Post Approval Study
Post-Approval study for the CardioMEMS Heart Failure (HF) system has completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: The Aortix CRS Pilot Study [NA]
A completed clinical trial update for the Aortix CRS Pilot Study (NCT04145635) involving heart failure with decompensation and cardiorenal s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-04-16FDA Approved: CARVEDILOL PHOSPHATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carvedilol phosphate from Sun Pharmaceutical, confirming approval of this generic salt formulati…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients [Phase 4]
Phase 4 clinical trial investigating dapagliflozin for efficacy and safety in improving heart failure among dialysis patients (recruiting).
-
FDA approval · 2024-04-12FDA Approved: ENTRESTO — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved ENTRESTO (sacubitril/valsartan) under the original application to treat chronic heart failure and reduce cardiovascular death i…
-
FDA approval · 2024-04-12FDA Approved: ENTRESTO — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for ENTRESTO (sacubitril/valsartan) from Novartis Pharmaceuticals, resulting in changes to its label…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF [Phase 4]
Phase 4 pilot study evaluating deprescribing beta-blockers using N-of-1 trials in patients with heart failure with preserved ejection fracti…
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure [Phase 4]
Phase 4 trial evaluating the effects of levosimendan on cardiac function after transcatheter aortic valve replacement in patients with heart…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Timely Recovery After Subclinical Heart Failure [Phase 4]
A Phase 4 clinical trial update on timely recovery after subclinical heart failure focuses on diastolic dysfunction.
-
FDA approval · 2024-04-02FDA Approved: FUROSEMIDE — Original Application (Devatis Inc.)
FDA approved Devatis Inc.'s original application for a generic furosemide product, enabling its marketing in the United States.
-
CLINICAL_TRIALS trial_result · 2024-03-28Clinical Trial Update: Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy. [Phase 4]
A Phase 4 clinical trial evaluating immunosuppression therapy for myocarditis or inflammatory cardiomyopathy, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Multiple Cardiac Sensors for the Management of Heart Failure [NA]
Clinical trial update for multiple cardiac sensors used in managing heart failure has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Sacubitril/Valsartan in Left Ventricular Assist Device Recipients [Phase 4]
A Phase 4 clinical trial evaluating sacubitril/valsartan in patients with heart failure who have a left ventricular assist device (LVAD).
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: Hemodynamic Effects of Modulating Circulating Ketone Bodies With 1,3-butanediol [Phase 2]
Phase 2 trial evaluating how modulating circulating ketone bodies with 1,3-butanediol affects hemodynamics in heart failure; study completed…
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Ingenio Device Algorithm Study [NA]
Completed clinical trial study updating a device algorithm for the Ingenio device, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Sugammadex Titration in Cardiac Surgery Patients [Phase 4]
A Phase 4 clinical trial updating sugammadex titration in cardiac surgery patients has completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Personalized Treatments for Depressive Symptoms in Patients With Advanced Heart Failure [Phase 4]
Phase 4 clinical trial update on personalized treatments for depressive symptoms in patients with advanced heart failure has completed with …
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Efficacy and Safety of Dapagliflozin in Acute Heart Failure [Phase 3]
Phase 3 trial update reports on the efficacy and safety of dapagliflozin in acute heart failure (completely enrolled and results posted).
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Effect of the PLAN CUIDARTE on the Caregiving Competence of People With Heart Failure [Phase 2]
Phase 2 clinical trial assessing the PLAN CUIDARTE program's impact on caregiver competence for people with heart failure.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure [NA]
The Cleveland Clinic's clinical trial examines oral sodium to preserve renal efficiency in acute heart failure. The study is listed as activ…
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Impact of Heart Failure Center Program on Cardiac Outcomes in Patients With Heart Failure
A completed clinical trial assessing the impact of a Heart Failure Center program on cardiac outcomes in patients with heart failure; result…
-
FDA approval · 2024-03-06FDA Approved: DOBUTAMINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for the dobutamine product from Hikma Pharmaceuticals USA Inc.